The Science of Gene Therapy for Hemophilia

The Science of Gene Therapy for Hemophilia is organized by National Hemophilia Foundation (NHF).

CME / ABIM MOC Released: 8/3/2018
Reviewed and Renewed: 9/6/2019
Available for Credit Until: Sunday, September 6, 2020

Description:
This webinar examines the technology behind the emerging approaches to gene therapy in hemophilia. Upon completion, participants will have increased knowledge regarding the use of gene therapy for hemophilia and of the mechanisms of gene therapy for hemophilia that affect immunity, efficacy and safety.

This activity is part of the “Clinical Advances in Gene Therapy for Hemophilia” educational series which is presented through a collaboration between Medscape, NHF, the European Haemophilia Consortium and the World Federation of Hemophilia. The program is supported by an independent educational grant from BioMarin.

Additional details will be posted as soon as information is available.